Avistone Pharmaceuticals
PrivateLast Round
Series B
Jan 4, 2024
Total Funding Raised
$340M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avistone Pharmaceuticals is a biotechnology company that develops innovative drugs for tumor treatment and precision oncology therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avistone Pharmaceuticals Comparables
Compare Avistone Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HaiHe Biopharma | 86% | |
| Apollomics | 84% | |
| HUTCHMED (China) Limited | 83% |
Avistone Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 4, 2024 | ||||
| Series A | Dec 8, 2021 |
Avistone Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series B |
| IDG Capital | Series B |
| Yanchuang Capital | Series B |
| SDIC Unity Capital | Series B |
| Bain Capital, LP | Series A, Series B |
| Primavera Capital Group | Series A |
| Vivo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 1041% MoM, from 81 to 924.
- Jun 1, 2025
Presented results at the ASCO Annual Meeting 2025.
Avistone Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avistone Pharmaceuticals's valuation, stock price, and market status.
Is Avistone Pharmaceuticals a public or private company?
Avistone Pharmaceuticals is a private company.
What is the current stock price of Avistone Pharmaceuticals?
Avistone Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Avistone Pharmaceuticals worth (valuation)?
Valuation information for Avistone Pharmaceuticals is not publicly available.
Can I buy Avistone Pharmaceuticals stock?
Avistone Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Avistone Pharmaceuticals's last funding round?
Avistone Pharmaceuticals's most recent funding round was Series B on January 4, 2024.
Who are the main investors in Avistone Pharmaceuticals?
Key investors in Avistone Pharmaceuticals include IDG Capital, Vivo Capital.
Will Avistone Pharmaceuticals IPO soon?
No public IPO plans have been announced for Avistone Pharmaceuticals.
How can I track Avistone Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avistone Pharmaceuticals's secondary market activity and sign up for updates.